Aclarion Inc (ACON)

$7.35 +0.05 (0.68%)
Market Cap 4.33M
Revenue (ttm) 50,000.00
Net Income (ttm) -6.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,980.00%
Debt to Equity Ratio 0.00
Volume 10,900
Avg Vol 34,824
Day's Range N/A - N/A
Shares Out 582,000.00
Stochastic %K 59%
Beta 1.21
Analysts Sell
Price Target $20.00

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs whi...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 275 2266
Address:
8181 Arista Place, Suite 100, Broomfield, United States
Imagiraffe
Imagiraffe Jun. 18 at 1:05 AM
$ACON Big ACON is gonna rips tomorrow! Letssss gooooo!
0 · Reply
amax777
amax777 Jun. 18 at 1:00 AM
$ACON strong in the after hours! She wants to maintain! Well keep consolidating before it’s ready to rip past $8
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 9:03 PM
$ACON It's still $7.35 ST not $7.20... WTF ??
0 · Reply
TradeMadeNow
TradeMadeNow Jun. 17 at 8:46 PM
$ACON Wait for News. They've got it plus plenty of cash for at least the next year.
0 · Reply
tusambolo
tusambolo Jun. 17 at 6:01 PM
$ACON could do what $CERO is doing today with a similar 1y chart Acon is just missing an after R/S run.
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 5:31 PM
$ACON Yes, @EpicComeback only 582,000 float...Bids are increasing nicely, always a sign of an impending explosion. The imminent Australia Expansion PR could send this to the moon...maybe well past that $30...
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 5:18 PM
$ACON $7.5824 now...$112,500/share VALUE using $RGC's metrics-- Crazy Crazy CRAZY Undervalued Stock - $22.93 in cash alone. $7.59 gets you $22.93 + a great Spine Surgery SaaS company...
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 3:15 PM
$ACON Yeah Buddy...Today's the Day WE party and @RocketTragic goes BK!!
0 · Reply
ROCKET_MAGIC
ROCKET_MAGIC Jun. 17 at 1:17 PM
$ACON 💀💀💀⬇️⬇️⬇️
0 · Reply
EpicComeback
EpicComeback Jun. 17 at 12:06 PM
$ACON nice float, she is ready to rip to $30
0 · Reply
Latest News on ACON
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 20, 2025, 6:00 AM EDT - 4 weeks ago

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 5 weeks ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Apr 29, 2025, 6:00 AM EDT - 7 weeks ago

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Apr 23, 2025, 6:00 AM EDT - 7 weeks ago

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 21, 2025, 6:00 AM EDT - 2 months ago

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 9, 2025, 7:00 AM EDT - 2 months ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Apr 2, 2025, 6:00 AM EDT - 2 months ago

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 31, 2025, 7:00 AM EDT - 2 months ago

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Aclarion Provides Shareholder Update

Mar 13, 2025, 9:25 AM EDT - 3 months ago

Aclarion Provides Shareholder Update

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Mar 6, 2025, 9:35 AM EST - 3 months ago

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Aclarion Announces First Commercial Agreement with Scripps Health

Mar 3, 2025, 6:00 AM EST - 3 months ago

Aclarion Announces First Commercial Agreement with Scripps Health

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Feb 20, 2025, 6:00 AM EST - 4 months ago

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 11, 2025, 7:58 AM EST - 4 months ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 6, 2025, 7:23 AM EST - 4 months ago

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Feb 4, 2025, 7:23 AM EST - 4 months ago

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Nov 21, 2024, 8:00 AM EST - 7 months ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Nov 14, 2024, 5:00 PM EST - 7 months ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 10, 2024, 7:00 AM EDT - 8 months ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 27, 2024, 6:57 AM EDT - 9 months ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 13, 2024, 8:30 AM EDT - 9 months ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Sep 12, 2024, 6:57 AM EDT - 9 months ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Sep 10, 2024, 6:57 AM EDT - 10 months ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Sep 5, 2024, 6:57 AM EDT - 10 months ago

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aug 29, 2024, 6:57 AM EDT - 10 months ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aug 21, 2024, 7:57 AM EDT - 10 months ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aug 15, 2024, 9:48 AM EDT - 10 months ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aclarion Announces First Commercial Agreement in Michigan

Aug 14, 2024, 8:08 AM EDT - 10 months ago

Aclarion Announces First Commercial Agreement in Michigan

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aug 13, 2024, 9:07 AM EDT - 11 months ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Jun 25, 2024, 8:30 AM EDT - 1 year ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Apr 25, 2024, 9:14 AM EDT - 1 year ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion Announces Closing of $3.0 Million Public Offering

Feb 27, 2024, 3:22 PM EST - 1 year ago

Aclarion Announces Closing of $3.0 Million Public Offering

Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 1 year ago

Aclarion Announces Pricing of $3.0 Million Public Offering

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Feb 5, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Jan 22, 2024, 8:00 AM EST - 1 year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Nov 27, 2023, 8:00 AM EST - 1 year ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Nov 6, 2023, 8:00 AM EST - 1 year ago

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Oct 25, 2023, 8:30 AM EDT - 1 year ago

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Oct 24, 2023, 8:45 AM EDT - 1 year ago

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Oct 23, 2023, 7:00 AM EDT - 1 year ago

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aug 25, 2023, 4:10 PM EDT - 1 year ago

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Jun 14, 2023, 11:27 AM EDT - 2 years ago

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

Jun 8, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

May 30, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

May 23, 2023, 7:30 AM EDT - 2 years ago

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

Aclarion, Inc. Announces Delayed 10-Q Filing

May 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion, Inc. Announces Delayed 10-Q Filing

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

May 19, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

Apr 28, 2023, 11:20 AM EDT - 2 years ago

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Mar 7, 2023, 9:19 AM EST - 2 years ago

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Imagiraffe
Imagiraffe Jun. 18 at 1:05 AM
$ACON Big ACON is gonna rips tomorrow! Letssss gooooo!
0 · Reply
amax777
amax777 Jun. 18 at 1:00 AM
$ACON strong in the after hours! She wants to maintain! Well keep consolidating before it’s ready to rip past $8
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 9:03 PM
$ACON It's still $7.35 ST not $7.20... WTF ??
0 · Reply
TradeMadeNow
TradeMadeNow Jun. 17 at 8:46 PM
$ACON Wait for News. They've got it plus plenty of cash for at least the next year.
0 · Reply
tusambolo
tusambolo Jun. 17 at 6:01 PM
$ACON could do what $CERO is doing today with a similar 1y chart Acon is just missing an after R/S run.
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 5:31 PM
$ACON Yes, @EpicComeback only 582,000 float...Bids are increasing nicely, always a sign of an impending explosion. The imminent Australia Expansion PR could send this to the moon...maybe well past that $30...
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 5:18 PM
$ACON $7.5824 now...$112,500/share VALUE using $RGC's metrics-- Crazy Crazy CRAZY Undervalued Stock - $22.93 in cash alone. $7.59 gets you $22.93 + a great Spine Surgery SaaS company...
0 · Reply
StockRedBaron
StockRedBaron Jun. 17 at 3:15 PM
$ACON Yeah Buddy...Today's the Day WE party and @RocketTragic goes BK!!
0 · Reply
ROCKET_MAGIC
ROCKET_MAGIC Jun. 17 at 1:17 PM
$ACON 💀💀💀⬇️⬇️⬇️
0 · Reply
EpicComeback
EpicComeback Jun. 17 at 12:06 PM
$ACON nice float, she is ready to rip to $30
0 · Reply
EpicComeback
EpicComeback Jun. 17 at 11:18 AM
$ACON could be the next $RGC
0 · Reply
amax777
amax777 Jun. 16 at 5:27 PM
$ACON if we crack $8 this week, she ain’t turning back. Let’s gooo!
0 · Reply
StockRedBaron
StockRedBaron Jun. 16 at 4:13 PM
$ACON $7.49 Green - Strong support for this OBSCENELY undervalued stock...$481 pt by SA...If you like her grab... some Aclarion!
0 · Reply
StockRedBaron
StockRedBaron Jun. 16 at 2:33 PM
$ACON Smart man! Aclarion is easily 10x the company RGC is, yet the shares are 7,000x backwards....$63,974 now...by RGC's value metrics. I mean WTF ???
0 · Reply
StockRedBaron
StockRedBaron Jun. 16 at 2:19 PM
$ACON $RGC Make that Aclarion $57,120...for $53.91...(RGC even higher). That $11,750 original price target by Ascendiant and that A1F Video look pale now...1/5 th of the relative pt! RGC has ZERO income. Aclarion has $52 K and growing income through London Clinic... plus $22.93 cash per share on hand!
0 · Reply
LordsofKarma7
LordsofKarma7 Jun. 16 at 2:16 PM
$RGC boom $ACON is next
0 · Reply
StockRedBaron
StockRedBaron Jun. 16 at 2:11 PM
$ACON $RGC Yeah, so now plug in RGC's Post Split Book Value metrics, it makes Aclarion $45,600 share. Today. Immediately. And Aclarion is USA 100%... RGC is Hong Kong BS.
1 · Reply
EpicComeback
EpicComeback Jun. 16 at 12:32 PM
$ACON expect this to be $35-$50 soon
1 · Reply
amax777
amax777 Jun. 16 at 12:40 AM
$ACON ACON did very well last week let’s continue that success as more and more people realize just how valuable this company is becoming!
0 · Reply
TradeMadeNow
TradeMadeNow Jun. 13 at 10:52 PM
$ACON Biotechs in early stages eat up a lot funding. Successful Biotechs at the revenue stage start Booming. Read the news on this one. Evaluate what stage you think they are at in the business cycle. The past is passed.
0 · Reply
ROCKET_MAGIC
ROCKET_MAGIC Jun. 13 at 8:36 PM
$ACON 💀💀💀 TOXIC Management and Pumpers don’t care about you. Stay safe this weekend everyone.
0 · Reply
StockRedBaron
StockRedBaron Jun. 13 at 7:19 PM
$ACON Back to $7.488...I just now asked Co-Pilot to speculate, based on what Radnet's prior acquisitions were paid, what they would offer for Aclarion...$17.18 to $51.54 per share. Here's the graphic:
0 · Reply